Jim Simons Avadel Pharmaceuticals PLC Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$12.55 - $17.22 $2.75 Million - $3.77 Million	-219,100 Reduced 35.05%	406,006 $6.86 Million
Q4 2023 Feb 13, 2024	SELL	$9.64 - $14.59 $1.1 Million - $1.66 Million	-113,800 Reduced 15.4%	625,106 $8.83 Million
Q3 2023 Nov 14, 2023	BUY	$10.3 - $15.99 $482,040 - $748,332	46,800 Added 6.76%	738,906 $7.61 Million
Q2 2023 Aug 11, 2023	SELL	$8.48 - $16.48 $1.08 Million - $2.1 Million	-127,648 Reduced 15.57%	692,106 $11.4 Million
Q1 2023 May 12, 2023	BUY	$6.41 - $9.95 $858,606 - $1.33 Million	133,948 Added 19.53%	819,754 $7.51 Million
Q4 2022 Feb 13, 2023	SELL	$5.02 - $10.0 $517,561 - $1.03 Million	-103,100 Reduced 13.07%	685,806 $4.91 Million
Q3 2022 Nov 14, 2022	SELL	$2.57 - $7.31 $167,307 - $475,881	-65,100 Reduced 7.62%	788,906 $3.95 Million
Q2 2022 Aug 12, 2022	BUY	$1.07 - $6.95 $106,679 - $692,915	99,700 Added 13.22%	854,006 $2.08 Million
Q1 2022 May 13, 2022	SELL	$5.46 - $8.29 $499,590 - $758,534	-91,500 Reduced 10.82%	754,306 $5.15 Million
Q4 2021 Feb 11, 2022	SELL	$7.34 - $11.18 $55,050 - $83,850	-7,500 Reduced 0.88%	845,806 $6.83 Million
Q3 2021 Nov 12, 2021	SELL	$6.49 - $9.91 $150,568 - $229,912	-23,200 Reduced 2.65%	853,306 $8.36 Million
Q2 2021 Aug 13, 2021	SELL	$6.73 - $9.05 $355,344 - $477,840	-52,800 Reduced 5.68%	876,506 $5.9 Million
Q1 2021 May 13, 2021	SELL	$6.61 - $10.07 $773,370 - $1.18 Million	-117,000 Reduced 11.18%	929,306 $8.4 Million
Q4 2020 Feb 10, 2021	SELL	$5.03 - $7.95 $957,596 - $1.51 Million	-190,377 Reduced 15.39%	1,046,306 $6.99 Million
Q3 2020 Nov 13, 2020	SELL	$5.02 - $8.98 $511,076 - $914,235	-101,808 Reduced 7.61%	1,236,683 $6.23 Million
Q2 2020 Aug 13, 2020	BUY	$7.25 - $11.75 $3.14 Million - $5.08 Million	432,685 Added 47.77%	1,338,491 $10.8 Million
Q1 2020 May 14, 2020	BUY	$4.06 - $10.64 $210,307 - $551,152	51,800 Added 6.07%	905,806 $7.19 Million
Q4 2019 Feb 13, 2020	BUY	$3.34 - $7.7 $106,880 - $246,400	32,000 Added 3.89%	854,006 $6.45 Million
Q3 2019 Nov 13, 2019	BUY	$1.92 - $4.47 $37,248 - $86,718	19,400 Added 2.42%	822,006 $3.42 Million
Q2 2019 Aug 12, 2019	BUY	$1.09 - $3.19 $157,254 - $460,221	144,270 Added 21.91%	802,606 $2.32 Million
Q1 2019 May 14, 2019	BUY	$1.44 - $3.29 $53,043 - $121,190	36,836 Added 5.93%	658,336 $948,000
Q4 2018 Feb 13, 2019	BUY	$1.74 - $4.66 $1.08 Million - $2.9 Million	621,500 New	621,500 $1.6 Million

Others Institutions Holding AVDL

# of Institutions

Shares Held

1.07M

Call Options Held

Put Options Held

View Full List

About AVADEL PHARMACEUTICALS PLC

Ticker AVDL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 60,581,300
Market Cap $650M
Description
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...

More about AVDL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account